<!DOCTYPE html>
<html>
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<meta name="viewport"content="target-densitydpi=device-dpi, initial-scale=1.0,user-scalable=no"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/style.css"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/estilos.css"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/flaticon.css"/>
	<script type="text/javascript" src="../assets/js/jquery.js"></script>
	<script type="text/javascript" src="../assets/js/functions.js"></script>
</head>
<body>
	<div id="contenedor">
		<div id="menu_slide">
			<div id="as" class="fonts_i"><i class="flaticon-text162"></i></div>
			<div class="fonts_i"><input type="range" id="slide" min="0" max="72" value="0"></div>
			<div id="am" class="fonts_i"><i class="flaticon-edit-text"></i></div>
		</div>
		<div id="btn_opciones"><i class="flaticon-font14 fonts"></i></div>
		<div id="menu_botones">
			<div class="menu_contenedor">
				<div id="btn_normal" class="botones-caja-lector"></div>
				<div id="btn_sepia" class="botones-caja-lector"></div>
				<div id="btn_noche" class="botones-caja-lector"></div>
			</div>
			<div class="menu_contenedor">
				<select id="select_font">
					<option value="arial">Arial</option>
					<option value="century">New Century</option>
					<option value="futura">Futura</option>
					<option value="gillsans">Gill Sans</option>
					<option value="RobotoLight">Roboto</option>
					<option value="timesNew">Times New Roman</option>
				</select>
			</div>
		</div>
		<div id="contenedor-texto">
			<h1 id="subtitulo">7. Treatment for painful diabetic neuropathy</h1>
			<p>
				The most cost-effective measure to prevent the onset and slow the progression of neuropathy in patients with diabetes mellitus is adequate glycemic control.<sup>1</sup>
				<br>
				<br>	
				<b>
					Recommendations of the American Academy of Neurology (in conjunction with the American Association of Neuromuscular and Electrodiagnostic Medicine and the American Academy of Physical Medicine and Rehabilitation-2011) for the treatment of painful diabetic neuropathy, based on evidence.
				</b>
				<ol type="a">
					<li><b>Anticonvulsants:</b></li>
					<ul>
						<li>Pregabalin should be indicated as a treatment for PDN (Level A).<sup>7</sup></li>
						<li>The gabapentin and sodium valproate may be considered for treatment of PDN (Level B).<sup>7</sup></li>
						<li>There is insufficient evidence to support or refute the use of topiramate for the treatment of PDN (Level U).<sup>7</sup></li>
						<li>Oxcarbazepine, lamotrigine and lacosamide should probably not be considered for the treatment of PDN (Level B).<sup>7</sup></li>
					</ul>
					<li><b>Antidepressants:</b></li>
					<ul>
						<li>Amitriptyline, venlafaxine, and duloxetine should be considered for the treatment of PDN (Level B). Data are insufficient to recommend one of these agents over the others.<sup>7</sup></li>
						<li>Venlafaxine may be added to gabapentin for a better response (Level C).<sup>7</sup></li>
						<li>There is insufficient evidence to support or refute the use of desipramine, imipramine, fluoxetine, or the combination of nortriptyline and fluphenazine for the treatment of PDN (Level U).<sup>7</sup></li>
					</ul>
					<li><b>Opiods:</b></li>
					<ul>
						<li>Dextromethorphan, morphine, tramadol, and oxycodone should be considered for the treatment of PDN (Level B).<sup>7</sup> ata are insufficient to recommend one agent over the other.<sup>7</sup></li>
					</ul>
					<li><b>Other treatments:</b></li>
					<ul>
						<li>Capsaicin and isosorbide dinitrate (spray) should be considered for the treatment of PDN (Level B).<sup>7</sup></li>
						<li>Lidocaine patch may be considered for the treatment of PDN (Level C).<sup>7</sup></li>
						<li>Clonidine, pentoxifylline, and mexiletine should probably not be considered for the treatment of PDN (Level B).<sup>7</sup></li>
						<li>There is insufficient evidence to support or refute the use of alpha lipoic acid in the treatment of PDN (Level U).<sup>7</sup></li>
					</ul>
					<li><b>Non-pharmacological measures:</b></li>
					<ul>
						<li>Percutaneous electrical nerve stimulation should be considered for the treatment of PDN (Level B).<sup>7</sup></li>
						<li>Electromagnetic field treatment, low-intensity laser treatment, and Reiki therapy should probably not be considered for the treatment of PDN (Level B).<sup>7</sup></li>
					<ul>
				</ol>
			</p>
		</div>
	</div>
</body>
</html>